Clinical Trial Update: SGLT-2 and DPP-4 Inhibition, Subclinical Inflammation of the Genito-urinary Tract and Risk of Infections.

View source ↗

Summary

A completed clinical trial evaluated the effects of SGLT-2 inhibition and DPP-4 inhibition on subclinical genito-urinary tract inflammation and infection risk i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus
• Urinary Tract Infection

Drugs mentioned

• DPP-4 inhibitors
• SGLT-2 inhibitors

Snippet

Sponsor: University of Pisa | Conditions: Type 2 Diabetes, Urinary Tract Infections | Status: COMPLETED